Screening for potentially teratogenic medications in the hospital setting: a necessity or a luxury?
International Journal of Pharmacy Practice · 21.08.2026
DOI: 10.1093/ijpp/riag101 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmacy Practice, online erschienen am 21.08.2026. Verfasst von Michael Ceulemans und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium. Die Arbeit nennt 10 Literaturangaben. Gefördert von: Senior Postdoctoral Fellowship fundamental research of the Research Foundation Flanders.
Abstract (Originalsprache)
Objectives
This study assessed the frequency and type of potentially teratogenic medications administered to hospitalized pregnant women.
Methods
A retrospective study was conducted among pregnant women hospitalized between 2021 and 2023. Key findings Among 155 individuals, 1058 medications were administered (mean: 6.8 per patient), including 77 potentially teratogenic medications (7.3%), corresponding to 27.1% of the cohort. Indomethacin (18.7%), tramadol (18.1%), and sufentanil (7.7%) were most common. Such medications were used nearly twice as often during non-pregnancy versus pregnancy-related admissions (12.7% vs. 6.8%).
Conclusions
The findings support the potential value of pregnancy-related monitoring, however, improving pregnancy documentation, especially in non-obstetric wards, remains essential.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium.
- L-C&Y, KU Leuven Child & Youth Institute, 3000 Leuven, Belgium.
- Research Foundation Flanders (FWO), 1000 Brussels, Belgium.
- Faculty of Pharmaceutical Sciences, KU Leuven, 3000 Leuven, Belgium.
- Pharmacy Department, University Hospitals Leuven, 3000 Leuven, Belgium.
- Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium.
ORCID-Profile: Michael Ceulemans
Förderung
- Senior Postdoctoral Fellowship fundamental research of the Research Foundation Flanders
Zitieren
APA
Ceulemans, M., Bruyninckx, L., Van den Broucke, E., Allegaert, K., Van Calsteren, K., Spriet, I., & Quintens, C. (2026). Screening for potentially teratogenic medications in the hospital setting: a necessity or a luxury?. International Journal of Pharmacy Practice. https://doi.org/10.1093/ijpp/riag101
Vancouver
Ceulemans M, Bruyninckx L, Van den Broucke E, Allegaert K, Van Calsteren K, Spriet I, et al. Screening for potentially teratogenic medications in the hospital setting: a necessity or a luxury?. International Journal of Pharmacy Practice. 2026. doi:10.1093/ijpp/riag101
BibTeX
@article{Ceulemans2026,
author = {Ceulemans, Michael and Bruyninckx, Lynn and Van den Broucke, Evelyne and Allegaert, Karel and Van Calsteren, Kristel and Spriet, Isabel and Quintens, Charlotte},
title = {Screening for potentially teratogenic medications in the hospital setting: a necessity or a luxury?},
journal = {International Journal of Pharmacy Practice},
year = {2026},
doi = {10.1093/ijpp/riag101}
}
EUVIMED